IRCT20201023049126N1 IRCT 2021-03-30 Shiraz University of Medical Sciences Sodium Valproate and Diabetic nephropathy Assess the effectiveness of Sodium valproate on level of albuminuria in patient with type 2 diabetes :A double-blind randomized clinical trial 2021-02-19 anticipated 60 Complete https://irct.ir/trial/53297 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The people who enter the study with a block randomization method and using the randomization.com site 60 people are placed in a 20-item block .finally, Sixty people are assigned drugs in three ways, Blinding description: Using a placebo with the same shape, color, smell, taste, and box as sodium valproate, the patient becomes blind to the type of drug (placebo or drug). The researcher who gives the drugs to the patients is not aware of the type of drug prescribed because the shape of the boxes is the same and only the code on the boxes is different. He/She does not aware of What do the codes mean and what kind of medicine does each code indicate. 3 diabetic nephropathy. Intervention 1: Intervention group1:twenty patients take sodium valproate 200 mg tablet of Destin company daily for 3 months. Intervention 2: Intervention group2: twenty patients take sodium valproate 200 mg of Destin company twice a day for 3 months. Intervention 3: Control group1: Twenty patients take a placebo made by Shiraz School of Pharmacy daily for three months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information